A Single Institutional Phase II Clinical Trial of Abraxane Combined With Cisplatin in Metastatic Breast Cancer.
Phase of Trial: Phase II
Latest Information Update: 01 Jan 2013
At a glance
- Drugs Cisplatin (Primary) ; Paclitaxel (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 21 Nov 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Nov 2011 Actual end date (November 2011) added as reported by ClinicalTrials.gov.
- 28 Jan 2011 Planned End Date changed from 1 Dec 2011 to 1 Jun 2011 as reported by ClinicalTrials.gov.